The rationale of antibiotic prophylaxis in total hip replacement arthroplasty.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001178:Arthroplasty; D001424:Bacterial Infections / Q000517:prevention & control*; D002177:Candidiasis / Q000517:prevention & control; D002509:Cephaloridine / Q000008:administration & dosage; D003023:Cloxacillin / Q000008:administration & dosage; D006615:Hip / Q000601:surgery*; D006801:Humans; D008034:Lincomycin / Q000008:administration & dosage; D011512:Proteus Infections / Q000517:prevention & control; D011552:Pseudomonas Infections / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000517:prevention & control; D013530:Surgical Wound Infection / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D008034:Lincomycin; D002509:Cephaloridine; D003023:Cloxacillin